A Standardized RANO Resection Classification Links Supramaximal Surgery to Meaningful Survival Gains in IDH‑Mutant Grade 2 Glioma
Highlights
– The RANO four‑tier classification of residual T2‑FLAIR tumour volume (class 1: supramaximal beyond FLAIR; class 2: 0–5 cm3 remnant; class 3: 5–25 cm3; class 4: >25 cm3) stratifies long‑term outcomes in IDH‑mutant grade 2 glioma.
– Supramaximal resection (class 1) yielded the best outcomes (10‑year overall survival 98%; 5‑year PFS 83%), with graded decrement in outcomes across classes 2–4.
– Survival benefits of more extensive resection appear earlier in astrocytomas (separation by ~3 years) than in oligodendrogliomas (separation at 6–8 years), but benefit is present across molecular subtypes.
– The classification was robust in multivariable models, in patients receiving first‑line adjuvant therapy, and in an independent UCSF validation cohort.
Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.